Microbot Medical Inc. (MBOT) - Dilution Analysis

10-K filing | 67.2M shares outstanding

10-Q filing | 67.2M shares outstanding

S-3/A filing: This is an S-3/A filing outlining the registrant's obligations and conditions regarding the offering of securities under the Securities Act of 1933, including liabilities, indemnification, and communication requirements.

S-3/A filing: This is an S-3/A filing with information about the terms under which the registrant will offer or sell securities to purchasers, and undertakings regarding liabilities under the Securities Act of 1933.

S-3 filing: This prospectus relates to the resale or other disposition from time to time of up to 14,688,572 shares of our common stock by the selling stockholders named in this prospectus that may be issued upon the exercise of outstanding preferred investment options held by the selling stockholders.

S-3 filing: This prospectus relates to the resale or other disposition from time to time of up to 900,153 shares of our common stock by the selling stockholders named in this prospectus, including their transferees, pledgees, donees or successors, that may be issued upon the exercise of outstanding preferred investment options held by the selling stockholders.

8-K filing: Microbot Medical Inc. issued 1,324,488 shares of common stock upon the exercise of series H preferred investment options at $2.10 per share, and issued 1,324,488 new series J preferred investment options. ($2.78M proceeds)

8-K filing: Microbot Medical Inc. reports the exercise of 600,000 series H preferred investment options for 600,000 shares of common stock at $2.10 per share. ($1.26M proceeds)

8-K filing: Microbot Medical Inc. completed the first closing of an inducement transaction, issuing 12,064,627 shares of common stock through the exercise of existing preferred investment options at prices ranging from $1.50 to $2.13 per share, resulting in gross proceeds of approximately $25.2 million. ($25.2M proceeds)

8-K filing: Microbot Medical Inc. issued 4,344,286 shares of its common stock upon the exercise of Series G preferred investment options at an exercise price of $1.75 per share, generating gross proceeds of approximately $7.6 million. ($7.6M proceeds)

8-K filing: Microbot Medical Inc. issued 1,808,336 shares of common stock upon the exercise of Series G and Series F preferred investment options, generating gross proceeds of approximately $2.975 million. ($2.98M proceeds)

8-K filing: Microbot Medical Inc. issued 1,480,504 shares of its common stock upon the exercise of Series E and Series F preferred investment options at an exercise price of $1.50 per share, generating gross proceeds of approximately $2.22 million. ($2.22M proceeds)

8-K filing: Microbot Medical Inc. increased the total number of authorized shares of common stock to 120,000,000, with a corresponding increase in total authorized shares to 121,000,000.

10-Q filing | 36.4M shares outstanding

8-K filing: Microbot Medical Inc. issued 1,533,336 shares of common stock upon the exercise of Series F and Series E preferred investment options at an exercise price of $1.50 per share, generating gross proceeds of approximately $2.3 million. ($2.3M proceeds)

POS AM filing: This prospectus relates to the resale of common stock by selling stockholders, including shares that may be issued upon the exercise of outstanding preferred investment options; it also details previous direct offerings and warrant issuances.

POS AM filing: This prospectus relates to the resale of up to 1,769,966 shares of common stock by selling stockholders upon exercise of outstanding preferred investment options.

POS AM filing: This POS AM filing on 2025-03-28 relates to the resale of up to 2,281,626 shares of common stock by selling stockholders upon exercise of preferred investment options.

POS AM filing: This POS AM filing relates to the resale or other disposition from time to time of up to 15,966,530 shares of common stock by selling stockholders, which may be issued upon the exercise of outstanding preferred investment options.

POS AM filing: This POS AM filing relates to the resale of common stock by selling stockholders and details of previous direct offerings and warrant issuances.

S-3/A filing: This prospectus relates to the resale of common stock by selling stockholders and describes previous registered direct offerings.

10-K filing | 34.7M shares outstanding

S-3 filing: This S-3 filing registers 12,542,268 shares of common stock for resale by selling stockholders and includes details of previous offerings.

8-K filing: Microbot Medical Inc. issued 6,103,289 shares of common stock at $2.13 per share in a registered direct offering, with gross proceeds of approximately $13.0 million, and also agreed to issue Series I warrants to purchase up to 12,206,578 shares of common stock. ($13.0M proceeds)

8-K filing: Microbot Medical Inc. completed multiple registered direct offerings and concurrent private placements in January 2025, raising gross proceeds of approximately $15.6 million and issuing shares of common stock and warrants. ($20.42M proceeds)

S-1/A filing: This S-1/A filing details multiple instances where the company issued warrants and shares of common stock upon exercise of preferred investment options in private placements and public offerings.

S-1 filing: This S-1 filing relates to the resale of 15,966,530 shares of common stock by selling stockholders upon exercise of outstanding preferred investment options.

8-K filing: Microbot Medical Inc. completed a registered direct offering of 3,788,550 shares of common stock at $2.27 per share, and agreed to issue Series H warrants to purchase up to 7,577,100 shares of common stock. ($8.6M proceeds)

8-K filing: Microbot Medical Inc. entered into Securities Purchase Agreements with institutional investors to issue and sell 4,000,001 shares of common stock at $1.75 per share in a registered direct offering, and also agreed to issue Series G preferred investment options to purchase up to 8,000,002 shares of common stock at an exercise price of $1.75 per share in a concurrent private placement. ($7.0M proceeds)

8-K filing: Microbot Medical Inc. completed an at-the-market offering, selling 4,276,486 shares of common stock for gross proceeds of $4,819,278 before deducting fees and expenses. The company is no longer selling shares under the ATM Agreement. As of January 3, 2025, the company had 20,242,119 shares of common stock issued and outstanding. ($4.82M proceeds)

10-Q filing | 16.5M shares outstanding

10-Q filing | 16.5M shares outstanding

S-1/A filing: This prospectus relates to the resale or other disposition from time to time of up to 3,211,671 shares of our common stock, $0.01 par value per share, by the selling stockholders named in this prospectus, including their transferees, pledgees, donees or successors, that may be issued upon the exercise of outstanding preferred investment options held by the selling stockholders.

S-1 filing: This prospectus relates to the resale by the selling stockholders identified in this prospectus of up to 3,211,671 shares of our common stock issuable upon the exercise of preferred investment options.

POS AM filing: This prospectus relates to the resale by the selling stockholders identified in this prospectus of up to 1,769,966 shares of our common stock, as follows: 1,685,682 shares of our common stock issuable upon the exercise of outstanding series E preferred investment options expiring in July 2029, at an exercise price per share of $1.50; 84,284 shares of our common stock issuable upon the exercise of outstanding preferred investment options expiring in July 2029, at an exercise price per share of $2.025.

8-K filing: Microbot Medical Inc. completed a registered direct offering of 1,566,669 shares of common stock at $1.50 per share, along with a concurrent private placement of Series F warrants to purchase up to 3,133,338 shares. ($2.35M proceeds)

POS AM filing: This prospectus relates to the sale or other disposition from time to time of up to 1,769,966 shares of our common stock representing shares issuable upon the exercise of outstanding preferred investment options held by the selling stockholders named in this prospectus, including their transferees, pledgees, donees or successors.

10-Q filing | 14.1M shares outstanding

S-1/A filing: This S-1/A filing registers 1,005,965 shares of common stock for resale by selling stockholders.

10-K filing | 14.4M shares outstanding

S-1 filing: This S-1 filing relates to the sale or other disposition from time to time of up to 1,005,965 shares of common stock held by selling stockholders.

8-K filing: Microbot Medical Inc. entered into a Settlement Agreement with Empery Asset Master Ltd., Empery Tax Efficient, LP, Empery Tax Efficient III, LP and Hudson Bay Master Fund Ltd. and issued 1,005,965 shares of restricted common stock as part of the settlement. ($1.05M proceeds)

S-1/A filing: This prospectus relates to the resale by the selling stockholders identified in this prospectus of up to 1,769,966 shares of our common stock, as follows: 1,685,682 shares of our common stock issuable upon the exercise of outstanding series E preferred investment options expiring in July 2029, at an exercise price per share of $1.50; 84,284 shares of our common stock issuable upon the exercise of outstanding preferred investment options expiring in July 2029, at an exercise price per share of $2.025.

S-1 filing: This prospectus relates to the resale by the selling stockholders identified in this prospectus of up to 1,769,966 shares of our common stock issuable upon the exercise of outstanding series E preferred investment options expiring in July 2029, at an exercise price per share of $1.50; 84,284 shares of our common stock issuable upon the exercise of outstanding preferred investment options expiring in July 2029, at an exercise price per share of $2.025.

8-K filing: Microbot Medical Inc. entered into an inducement letter agreement with certain holders to exercise existing investment options for 1,685,682 shares of common stock at a reduced price of $1.62 per share, expecting gross proceeds of approximately $2.73 million. ($2.73M proceeds)

S-3/A filing: The filing is for a shelf offering of common stock, preferred stock, and debt securities with a total value of up to $75,000,000.

S-3 filing: The filing is an S-3 form registering an indeterminate number of shares of common stock and preferred stock, an indeterminate principal amount of debt securities, warrants and rights to purchase common stock, preferred stock or debt securities, and such indeterminate number of units, as shall have an aggregate initial offering price not to exceed $75,000,000.

10-Q filing | 11.7M shares outstanding

10-Q filing | 11.7M shares outstanding

S-1/A filing: The company filed an S-1/A on 2023-07-14 and included information on private placements and public offerings of warrants and common stock.

S-1 filing: This S-1 filing relates to the resale of up to 2,281,626 shares of common stock by selling stockholders.

8-K filing: Microbot Medical Inc. completed a registered direct offering of 624,618 shares of common stock at $3.25 per share, along with a concurrent private placement of Series D warrants to purchase up to 312,309 shares, and issued warrants to Wainwright to purchase 31,231 shares. ($2.0M proceeds)

8-K filing: Microbot Medical Inc. sold 701,756 shares of common stock at $2.1375 per share in a registered direct offering, generating gross proceeds of approximately $1.5 million. ($1.5M proceeds)

8-K filing: Microbot Medical Inc. completed a registered direct offering, selling 975,000 shares of common stock at $2.20 per share and pre-funded warrants for 234,500 shares at $2.1999 per warrant, resulting in gross proceeds of approximately $2.66 million. ($2.66M proceeds)

8-K filing: Microbot Medical Inc. completed a registered direct offering of 655,569 shares of common stock at $2.20 per share, resulting in gross proceeds of approximately $1.4 million. ($1.4M proceeds)

10-Q filing | 8.0M shares outstanding

10-K filing | 8.1M shares outstanding

10-Q filing | 7.1M shares outstanding

8-K filing: Microbot Medical Inc. completed a registered direct offering and concurrent private placement on October 21, 2022, issuing 782,495 shares of common stock and pre-funded warrants for 240,000 shares at $4.89 and $4.8899 respectively, along with warrants to purchase 1,022,495 Series A and 1,022,495 Series B shares at $4.64. ($5.0M proceeds)

10-Q filing | 7.1M shares outstanding

10-Q filing | 7.1M shares outstanding

10-K filing | 7.1M shares outstanding

10-Q filing | 7.1M shares outstanding

10-Q filing | 7.1M shares outstanding

10-Q filing | 7.1M shares outstanding

10-K filing | 7.1M shares outstanding

S-3 filing: The filing registers an indeterminate number of shares of common stock and preferred stock, debt securities, warrants and rights to purchase common stock, preferred stock or debt securities, and units, with an aggregate initial offering price not to exceed $75,000,000.

10-Q filing | 7.1M shares outstanding

10-Q filing | 7.1M shares outstanding

10-Q filing | 7.1M shares outstanding

10-K filing | 7.1M shares outstanding

8-K filing: Microbot Medical Inc. announced that the Appellate Division affirmed the decision of the Trial Court in the lawsuit with Sabby Healthcare Master Fund Ltd. and Sabby Volatility Warrant Master Fund Ltd., requiring the return of 83,333 shares (post-stock split) to the Company and the return of $3.375 million to the Plaintiffs. ($3.38M proceeds)

8-K filing: Microbot Medical Inc. entered into a Securities Purchase Agreement for the issuance and sale of 900,901 shares of common stock at $11.10 per share, with gross proceeds of approximately $10 million, expected to close on December 31, 2019. ($10.0M proceeds)